National / Science & Health Aug 27, 2015
Health ministry approves new hepatitis C drug under insurance scheme
The tablet drug Harvoni is expected to revolutionize the treatment of patients with hepatitis C genotype 1, which accounts for about 70 percent of all hepatitis C patients in Japan.